SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-008889
Filing Date
2023-12-15
Accepted
2023-12-15 17:25:52
Documents
64
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR OCTOBER 2023 pharmacyte_i10q-103123.htm   iXBRL 10-Q 940386
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 9199
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 9185
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4627
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4701
  Complete submission text file 0001683168-23-008889.txt   5019680

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pmcb-20231031.xsd EX-101.SCH 40087
7 XBRL CALCULATION FILE pmcb-20231031_cal.xml EX-101.CAL 48157
8 XBRL DEFINITION FILE pmcb-20231031_def.xml EX-101.DEF 193120
9 XBRL LABEL FILE pmcb-20231031_lab.xml EX-101.LAB 287901
10 XBRL PRESENTATION FILE pmcb-20231031_pre.xml EX-101.PRE 266748
58 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_i10q-103123_htm.xml XML 726318
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-40699 | Film No.: 231491462
SIC: 2836 Biological Products, (No Diagnostic Substances)